These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 16439191

  • 1. Strontium ranelate: a physiological approach for optimizing bone formation and resorption.
    Marie PJ.
    Bone; 2006 Feb; 38(2 Suppl 1):S10-4. PubMed ID: 16439191
    [Abstract] [Full Text] [Related]

  • 2. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.
    Marie PJ.
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S11-5. PubMed ID: 16735840
    [Abstract] [Full Text] [Related]

  • 3. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro.
    Bonnelye E, Chabadel A, Saltel F, Jurdic P.
    Bone; 2008 Jan; 42(1):129-38. PubMed ID: 17945546
    [Abstract] [Full Text] [Related]

  • 4. Strontium ranelate: a novel mode of action optimizing bone formation and resorption.
    Marie PJ.
    Osteoporos Int; 2005 Jan; 16 Suppl 1():S7-10. PubMed ID: 15578159
    [Abstract] [Full Text] [Related]

  • 5. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages.
    Ortolani S, Vai S.
    Bone; 2006 Feb; 38(2 Suppl 1):19-22. PubMed ID: 16455319
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.
    Adami S.
    Bone; 2006 Feb; 38(2 Suppl 1):23-7. PubMed ID: 16434247
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Strontium ranelate: a physiological approach for an improved bone quality.
    Ammann P.
    Bone; 2006 Feb; 38(2 Suppl 1):15-8. PubMed ID: 16455318
    [Abstract] [Full Text] [Related]

  • 10. Strontium as therapy for osteoporosis.
    Marie PJ.
    Curr Opin Pharmacol; 2005 Dec; 5(6):633-6. PubMed ID: 16183330
    [Abstract] [Full Text] [Related]

  • 11. Improvement in bone strength parameters. The role of strontium ranelate.
    Tournis S.
    J Musculoskelet Neuronal Interact; 2007 Dec; 7(3):266-7. PubMed ID: 17947810
    [Abstract] [Full Text] [Related]

  • 12. Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
    Neuprez A, Hiligsmann M, Scholtissen S, Bruyere O, Reginster JY.
    Adv Ther; 2008 Dec; 25(12):1235-56. PubMed ID: 19066755
    [Abstract] [Full Text] [Related]

  • 13. Strontium ranelate in the prevention of osteoporotic fractures.
    Reginster JY, Malaise O, Neuprez A, Bruyere O.
    Int J Clin Pract; 2007 Feb; 61(2):324-8. PubMed ID: 17263720
    [Abstract] [Full Text] [Related]

  • 14. Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats.
    Ammann P, Shen V, Robin B, Mauras Y, Bonjour JP, Rizzoli R.
    J Bone Miner Res; 2004 Dec; 19(12):2012-20. PubMed ID: 15537445
    [Abstract] [Full Text] [Related]

  • 15. [Therapeutic agents for disorders of bone and calcium metabolism. Osteoporotic fracture prevention by strontium ranelate].
    Nakamura T.
    Clin Calcium; 2007 Jan; 17(1):80-7. PubMed ID: 17211097
    [Abstract] [Full Text] [Related]

  • 16. [Strontium ranelate's (Osseor) dual mode of action: increasing bone mass and decreasing bone resorption].
    Kaliterna DM.
    Reumatizam; 2008 Jan; 55(2):73-4. PubMed ID: 19024281
    [Abstract] [Full Text] [Related]

  • 17. Addressing and meeting the needs of osteoporotic patients with strontium ranelate: a review.
    Boonen S.
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S21-7. PubMed ID: 16735842
    [Abstract] [Full Text] [Related]

  • 18. A new treatment for post-menopausal osteoporosis: strontium ranelate.
    Rizzoli R.
    J Endocrinol Invest; 2005 Jun; 28(8 Suppl):50-7. PubMed ID: 16323829
    [Abstract] [Full Text] [Related]

  • 19. Strontium ranelate: a new paradigm in the treatment of osteoporosis.
    Reginster JY, Deroisy R, Jupsin I.
    Drugs Today (Barc); 2003 Feb; 39(2):89-101. PubMed ID: 12698204
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.